NanoSynex is a MedTech company that aims to revolutionize the diagnostic process and reduce healthcare costs. They specialize in providing new solutions to improve testing quality and speed by utilizing their rapid innovative Antimicrobial Susceptibility Test (AST). This cutting-edge technology, based on a phenotypic approach, optimizes bacterial growth and is implemented through a microfluidic disposable test card platform.

NanoSynex's core technology was developed by Professor Shulamit Levenberg, a former Dean of the Technion Institute of Technology – Biomedical Engineering Faculty. Their team consists of dedicated business executives, top-notch biomedical engineers, and microbiologist experts. They are also supported by a network of specialists and strategic alliances with future distributors to bring their groundbreaking product to the market.

NanoSynex has been recognized for their achievements and has won multiple awards, demonstrating their expertise and commitment to innovation in the healthcare industry